Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884359 · ClinicalTrials.gov registry record
Left Bundle Branch Area Mapping for Conduction System Pacing
A clinical trial of Pacemaker DDD and Left Bundle-Branch Block, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05884359: Recruiting study of Pacemaker DDD and Left Bundle-Branch Block, sponsored by Steward St. Elizabeth's Medical Center of Boston.
NCT05884359 is a study of Pacemaker DDD and Left Bundle-Branch Block that is actively recruiting participants, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05884359, a study of Pacemaker DDD and Left Bundle-Branch Block, is actively recruiting participants, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will utilize 3D mapping as a tool to explore electro-anatomical and electrocardiographic characteristics of the Left Bundle Branch Area. We plan on prospectively reviewing the data found from 3D mapping the left bundle branch implantation cases and using the data to improve understanding of electro-anatomical characteristics of this area for a better definition of the implantation target and depth.
Primary Outcome
Electroanatomical metrics
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 3D Electroanatomical Mapping (NavX)
Study Locations (1)
Massachusetts
- St. Elizabeth's Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-12 |
What NCT05884359 shows while recruiting
NCT05884359 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 2 conditions, with Pacemaker DDD appearing as the primary indexed condition, and to 1 intervention - of which 3D Electroanatomical Mapping (NavX) is the first listed.
NCT05884359 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05884359 about?
NCT05884359 is a clinical study titled "Left Bundle Branch Area Mapping for Conduction System Pacing". This study will utilize 3D mapping as a tool to explore electro-anatomical and electrocardiographic characteristics of the Left Bundle Branch Area. We plan on prospectively reviewing the data found from 3D mapping the left bundle branch implantation cases and using the data to improve understanding ...
What is the current status of trial NCT05884359?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-06-01. Estimated completion is 2026-12.
What conditions does trial NCT05884359 study?
This clinical trial studies the following conditions: Pacemaker DDD, Left Bundle-Branch Block.
What interventions are being tested in trial NCT05884359?
The interventions under investigation include: 3D Electroanatomical Mapping (NavX) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05884359?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884359 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pacemaker DDD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI